Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
Journal: The New England journal of medicine
Published: September 28, 2022
Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.
Journal: The Journal of clinical investigation
Published: March 03, 2015
Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial.
Journal: The lancet. Diabetes & endocrinology
Published: March 14, 2014
Showing 1-3 of 3
Last Updated: 09/26/2026